Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Quick facts
Marketed products
- Complete a 7-day course
- Dextromethorphan 15 milligrams
- Effervescent paracetamol termalgin · Pain management
Paracetamol inhibits prostaglandin synthesis by blocking cyclooxygenase enzymes, reducing pain and fever. - Fosfomycin Trometamol Salt
- Hydroxide Potassium
- Ipratropium Bromide 20Micrograms Inhaler
- Non- effervescent Paracetamol kern · Pain Management
Paracetamol inhibits prostaglandin synthesis by blocking cyclooxygenase enzymes in the central nervous system, reducing pain and fever.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina portfolio CI brief
- Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina pipeline updates RSS
Frequently asked questions about Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
What are Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina's marketed drugs?
Top marketed products include Complete a 7-day course, Dextromethorphan 15 milligrams, Effervescent paracetamol termalgin, Fosfomycin Trometamol Salt, Hydroxide Potassium, Ipratropium Bromide 20Micrograms Inhaler.